AI endoscopy to predict Crohn's return after surgery
Part of Digestive system clinical trials.
This trial uses artificial intelligence during colonoscopy to predict if Crohn's disease will come back after surgery. It aims to improve early detection and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had Crohn's disease for at least 6 months.
- You have had or will have surgery to remove a part of your intestine.
- You do not have a stoma (an opening in your belly for waste).
- You are not pregnant or breastfeeding.
- You are not allergic to nuts, shellfish, or fluorescein dye (used in a special imaging option).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to choose biologic (targeted) medicines after Crohn’s surgery to help stop Crohn’s from coming back in the bowel. It may help you avoid or delay repeat inflammation by adjusting treatment based on endoscopy findings.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
This study tests whether an artificial intelligence (AI) system can help doctors find signs of Crohn's disease better than standard reading of capsule endoscopy images. It is for people who have symptoms that might be Crohn's but whose colonoscopy didn't clearly show the problem.
This pilot study uses a special AI-powered camera and a safe fluorescent dye during your scheduled colonoscopy to map how much fluid leaks through your gut lining. The goal is to better understand gut barrier damage in inflammatory bowel disease and help doctors assess disease severity.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.